Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
QuintilesIMS
Citi
Colorcon
Federal Trade Commission
Cantor Fitzgerald

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 8,883,763

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,883,763
Title:Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same
Abstract: The use of isoquinolones for preparing drugs, including novel isoquinolones as well as their synthesis method. In particular, isoquinolone derivatives used in the treatment of pathological angiogenesis, and more particularly of cancer.
Inventor(s): Popov; Andrei (Voreppe, FR), Juhem; Aurelie (Grenoble, FR), Florent; Jean-Claude (Gif sur Yvette, FR), N\'Guyen; Chi-Hung (Antony, FR)
Assignee: Universite Joseph Fourier (Grenoble, FR) Centre National de la Recherche Scientifique (Paris, FR) Institut Curie (Paris, FR)
Application Number:13/581,830
Patent Claims:see list of patent claims

Details for Patent 8,883,763

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Sign Up Universite Joseph Fourier (Grenoble, FR) Centre National de la Recherche Scientifique (Paris, FR) Institut Curie (Paris, FR) 2030-03-01 RX Orphan search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 003 2006-09-27 ➤ Sign Up Universite Joseph Fourier (Grenoble, FR) Centre National de la Recherche Scientifique (Paris, FR) Institut Curie (Paris, FR) 2030-03-01 RX search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 002 2006-09-27 ➤ Sign Up Universite Joseph Fourier (Grenoble, FR) Centre National de la Recherche Scientifique (Paris, FR) Institut Curie (Paris, FR) 2030-03-01 RX search
Amgen VECTIBIX panitumumab INJECTABLE; IV (INFUSION) 125147 001 2006-09-27 ➤ Sign Up Universite Joseph Fourier (Grenoble, FR) Centre National de la Recherche Scientifique (Paris, FR) Institut Curie (Paris, FR) 2030-03-01 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Sign Up Universite Joseph Fourier (Grenoble, FR) Centre National de la Recherche Scientifique (Paris, FR) Institut Curie (Paris, FR) 2030-03-01 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Sign Up Universite Joseph Fourier (Grenoble, FR) Centre National de la Recherche Scientifique (Paris, FR) Institut Curie (Paris, FR) 2030-03-01 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Teva
Medtronic
Cipla
McKinsey
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.